Clinical Trials Logo

Clinical Trial Summary

This is a phase 1, open-label study to assess the pharmacokinetics, pharmacodynamics, safety, and tolerability of opicapone when administered orally once daily for 14 days as adjunctive therapy to carbidopa/levodopa in subjects with Parkinson's disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03496870
Study type Interventional
Source Neurocrine Biosciences
Contact Cheryl Chen
Phone 858-617-7744
Email cechen@neurocrine.com
Status Recruiting
Phase Phase 1
Start date February 8, 2018
Completion date June 2018

See also
  Status Clinical Trial Phase
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Recruiting NCT03257046 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease Phase 1/Phase 2
Recruiting NCT03295786 - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease Phase 1/Phase 2
Completed NCT03103399 - Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon Phase 2
Recruiting NCT03104725 - Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease? N/A
Recruiting NCT03014050 - Bio Electro Stimulation Therapy for Parkinson's Disease N/A
Not yet recruiting NCT03582371 - Aqua Stand-Up Paddle Balance Effect in Parkinson's Disease (AquaSUP PARK) N/A
Not yet recruiting NCT03439943 - Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease Phase 2
Not yet recruiting NCT03575195 - Microbiota Intervention to Change the Response of Parkinson's Disease Phase 1/Phase 2
Not yet recruiting NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Not yet recruiting NCT03551392 - Pilot Intervention With Near Infrared Stimulation N/A
Recruiting NCT02823158 - Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM N/A
Recruiting NCT03143374 - Positron Emission Tomography (PET) Imaging of Tau Pathology in Neurodegenerative Disease N/A
Recruiting NCT02385500 - Fesoterodine on Urgency Episodes in Parkinson's Disease Population Phase 4
Recruiting NCT02897063 - Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Phase 1
Recruiting NCT03045211 - Post-Physical Therapy Extension of In-Home Dynamic Standing Table Use in Parkinson Disease N/A
Recruiting NCT02869945 - Compensation Mechanisms in Parkinson's Disease N/A
Recruiting NCT03192046 - Bracing for Walking in Parkinson's Disease N/A
Recruiting NCT02601586 - Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease Phase 2/Phase 3